The aim of the study was to investigate the metabolic function of intestinal microflora in children with celiac disease (CD) in order to find out if there is a deviant gut flora in CD patients compared to healthy controls.
INTRODUCTION
Celiac disease (CD) is characterized by a lesion of the mucosa of the proximal small bowel in genetically predisposed individuals following gluten consumption (1) (2) (3) . Treatment with gluten-free diet (GFD) leads to a normal mucosa in the light-microscopic investigations and clinical symptoms disappear. When gluten is reintroduced, the mucosal lesions reappear. CD is considered to be a lifelong condition. It affects mainly individuals with the HLA DQA1 * 0501 and DQB1 * 0201 genes encoding the DQ2 molecule (2) . Besides gluten, other environmental factors such as the composition and metabolic activity of the gastrointestinal (GI) microflora, might be involved in the pathogenesis of the disease. Soon after birth, the GI tract is colonized with bacteria and complex populations are established (4) (5) (6) (7) . So far, several hundreds Part of this study was presented at the 10th International Symposium on Coeliac Disease, June 2-5, 2002, Paris, France.
of species have been found in the GI tract. The balance between the host, the GI microflora, and the environment may be affected by various factors, e.g., antimicrobial treatment, various diseases, dietary variations including probiotics, malnutrition, and starvation (8) .
There are principally two ways to investigate the GI microflora in fecal samples: (1) a quantitative and qualitative evaluation of the microflora and (2) an analysis of the products of microbial metabolism (microflora associated characteristics, MACs). A MAC has been defined as the recording of any anatomical structure, physiological, biochemical, or immunological function in an organism, that has been influenced by the microflora in either an anabolic or a catabolic way (9) . Recently, Forsberg et al. (10) performed a microbial evaluation of the microflora. By scanning electron microscopy, they detected rod-shaped bacteria frequently associated with the mucosa of the small intestine in CD patients with active as well as inactive disease but not in controls.
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The aim of the present study was to make a functional evaluation of the status of the intestinal microflora and its impact on children with CD utilizing the MAC concept.
MATERIALS AND METHODS
Patients
The study was performed between March 1996 and January 2002 at the Pediatric Clinic, Norrköping Hospital, Sweden. The study group comprised children consecutively investigated due to suspected or manifest CD. Using a pediatric double-port Storz capsule (Karl Storz AG, Germany), small bowel biopsy was performed at the level of ligamentum Treitz. Mucosal specimens were light-microscopically classified and graded according to Walker-Smith et al. (11) . CD was diagnosed according to the criteria formulated by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (12) , including information regarding serum antibodies toward gliadin, endomysium, and/or transglutaminase.
Thirty-six children (12 boys, 24 girls; median age 4.7 yr, range 0.7-9.9 yr) with CD were studied at presentation, i.e., on a normal gluten-containing diet, with clinical symptoms and signs indicative of CD, positive celiac serology markers, and small bowel biopsy showing severe enteropathy. Fortyseven celiac children (21 boys, 26 girls; median age 4.2 yr, range 1.1-10.3 yr) were studied when they had been on GFD for at least 3 months. For comparison, fecal samples from 42 healthy children (HC) (23 boys and 19 girls; median age 3.0 yr, range 0.25-5.75 yr) were investigated. These children were recruited from children's welfare clinics in the town of Norrköping and surrounding rural districts. They were all on a normal, gluten-containing diet and had no signs of malnutrition.
The children were not matched with regard to age and sex in this study. None of the children in this study had been treated with antibiotics within 3 months prior to the fecal sampling. CD children at presentation, i.e., on a normal glutencontaining diet, delivered fecal samples before they started a GFD. In the celiac children on a GFD and the HC children, fecal samples were taken on 1-4 occasions with a 3-month interval over a period of 1 yr without any dietary changes regarding gluten intake. The fecal samples were frozen immediately or at least within 20 min of passage, and stored at −20
• C pending analysis.
Microflora Associated Characteristics
Short chain fatty acid (SCFA) analyses were performed on the fecal samples at Karolinska Institute, Stockholm, Sweden. The fecal material was homogenized after addition of distilled water containing 3 mmol/L of 2-ethylbutyric acid (=internal standard) and H 2 SO 4 (0.5 mmol/L); 2 mL of the homogenate was vacuum distilled, according to the method of Zijlstra et al. (13) , modified by Höverstad et al. (14) . The distillate was analyzed with gas-liquid chromatography and quantitated using internal standardization. Flame ionization detection was employed. The results were expressed in mmol/kg wet weight.
The following SCFAs were analyzed: acetic acid, propionic acid, i-butyric acid, n-butyric acid, i-valeric acid, n-valeric acid, i-caproic acid, and n-caproic acid.
Statistical Analysis
The statistical evaluation was performed by Student's t-test. A p value less than 0.05 was considered significant. The correlation between the i-butyric and i-valeric acids in each group was tested with the Spearman rank correlation coefficient r 2 . A coefficient r 2 above 0.70 is considered as a strong and above 0.90 as a very strong correlation.
Ethical Considerations
The study was approved by the Research Ethics Committee of Linköping University, Sweden.
RESULTS
The results of the analysis of SCFA in fecal samples are presented in Table 1 . There was a significantly higher level of acetic, i-butyric, and i-valeric acid as well as total SCFAs in children with CD, both before and during treatment with GFD, compared to the findings in HC. The propionic and nvaleric acids differed significantly between CD children on GFD compared to HC. There was no significant difference in SCFAs between children with untreated and treated CD. Moreover, the SCFA pattern did not differ significantly in celiac children less than 6 yr of age compared to those between 6 and 10.
The correlation between i-butyric and i-valeric acids was very strong in HC as well as in untreated and treated children with CD ( Fig.1 ) (r 2 = 0.9296).
DISCUSSION
The SCFA pattern reflects the gut flora-diet cross talks. Presence of longer SCFAs (valeric and caproic acids) represents anabolic processes performed under anaerobic conditions. The major representatives, acetic, propionic, and n-butyric acids are the end products of the intestinal degradation of carbohydrates and reflect catabolic processes enhanced by a limited presence of oxygen. It is generally assumed that branched acids, i.e., the isoforms, are metabolic products from the breakdown of proteins and lipids (15) . For the host, the SCFAs principally represent an important energy source for the colonocytes. Especially butyric acid enhances the kinetics of enterocytes (16) . Thus, the SCFAs serve as a nutritional reserve for the gut mucosal lining. SCFAs are also thought to be crucial for the regulation of intestinal motility and act antidiarrhoic. Furthermore, some SCFAs may protect against certain intestinal pathogenic microorganisms (17) . The major findings in the present study are significantly higher levels of acetic, i-butyric, and i-valeric acid, and the total amount of SCFAs in CD patients compared to HC. Interestingly, this difference remained after GFD in CD individuals (Table 1) . Our results display differences in metabolic ac- • = Untreated celiac disease; = Treated celiac diease; = Healthy controls.
tivity in the gut between CD and HC, which could indicate that some breakdown of carbohydrates and proteins takes place in the small intestine, which is the major localization of enteropathy in CD. It can be hypothesized that this might be due to an altered composition of bacterial flora in the small bowel (18) . Alternatively, a rapid small bowel passage or decreased metabolic activity caused by the proximal small bowel enteropathy and malabsorption in patients with untreated CD may result in an overload of undigested nutrients in the distal small bowel and the colon. The crypt hyperplasia, that develops in parallel with the villous atrophy, indicates a high cell turnover in the small intestine. The cells are expelled and increase the amount of substrate yielding branched SCFAs (17) . The HC include children up to the age of 6 yr, whereas the CD children reached the age of 10. In our material, no significant difference in SCFA pattern was shown between the younger and older celiac children. It has previously been shown that an adult flora seems to be established already at the age of 2 yr (5).
We have recently reported on the fecal SCFAs in pigs, rats, horses, and humans of different ages and fed on different diets (19) . Despite differences in the total output of SCFAs, there was a very strong correlation between the i-butyric and the i-valeric acids. This is in accordance with the results of the present study. We hypothesize that the strong correlation between the i-butyric and i-valeric acids is caused by the high intestinal cell turnover leading to large amounts of endogenous proteins presented to the gut flora.
There is very little information in the literature regarding the gut flora in patients with CD, which may be used for comparison. There is, however, some evidence in favor of an involvement of microbial factors in the pathogenesis of the disease. It is a well known clinical fact that CD in children often is preceded by a period of gastroenteritis. It has also been suggested that (20) , although questioned by others (21) , CD may be triggered in a genetically predisposed individual exposed to an intestinal adenovirus 12 infection through a cross-reaction between gliadin and an adenovirus 12 protein at the level of the T-cell receptor interaction. Other enteric adenoviruses have also been implicated in the etiology of CD (22), substantiated by the observation of a significant seasonal variation of the incidence of CD (23, 24) . The explanation for this difference might be the fact that children born during the summer are weaned during the winter when there is an increased risk for infections which in turn may damage the mucosal integrity.
In addition to circumstantial evidence of a microbial involvement in the pathogenesis of CD, Forsberg et al. (10) recently presented more hard evidence. They found rod-shaped bacteria in the upper small bowel in one-third of the children with CD but in less than 2% of the controls. Both some patients with recently diagnosed CD and those in remission on GFD carry the bacteria attached to their enterocytes. These findings were further discussed in an Editorial (25) . However, Forsberg et al. hypothesize that an altered mucosal glycosylation, in some celiacs, results in a changed bacterial flora.
This might lead to a functional change in the gut. We have shown that microorganisms may influence the glycosylation in the intestinal mucosa (26) (27) (28) . Therefore, it is still uncertain whether it is an altered glycosylation per se in CD, or an altered bacterial flora that causes the changed glycosylation.
In view of the fact that CD is a rare disease in Estonia (29) but one of the most common chronic disorders in the Swedish pediatric population (24) , it may be speculated that some intestinal microbes exert a protective effect against development of CD, whereas others may trigger the disease process. From this point of view, it is of interest to note that there seems to be major differences in the intestinal microflora between Estonian and Swedish infants (30) .
Schuppan and Hahn (31) focused attention on the importance of some external factors involved in GI gluten processing. They discussed in particular the activity of pancreatic and small intestinal proteases and the small intestinal microbial milieu, which in turn might affect small intestinal epithelial permeability by permitting passage of gluten peptides across the mucosal membranes. Shan et al. (32) proposed that dietary supplementation with bacterial peptidases might help to destroy major immunodominant gliadin epitopes, thereby making gluten nontoxic to patients with CD. If this holds true, it could offer a new way of treating CD. An interesting hypothesis is that gliadins might be deamidated by luminal transglutaminase (33) . If so, it might be reasonable to hypothesize that an increased deamidation in a celiac patient might lead to a microbial production of SCFAs.
In conclusion, our finding that children with CD, irrespective of dietary treatment, have an altered fecal SCFA profile compared to HC has, to the best of our knowledge, not previously been reported. It may be a genuine phenomenon not affected by either the diet, the inflammation, or the autoimmune status of the patient. Our finding may well reflect a deviant gut flora in CD patients, which may be a new piece of the intriguing puzzle of the pathogenesis of CD.
